Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FERGI: Pictilisib or Apitolisib with Fulvestrant in Advanced Breast Cancer
NCT01437566Phase 2Completed
- Sponsor
- Genentech
- Start
- Oct 2011
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 2 trial of pictilisib, apitolisib in breast cancer, sponsored by Genentech. Started Oct 2011; status: completed.
02
Drugs
pictilisibapitolisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01437566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01437566.